Royalty Pharma plc Number of Reporting Units
Royalty Pharma plc (RPRX) reported Number of Reporting Units of 1 reporting_unit for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Notes
us-gaap:NumberOfReportingUnits · last filed 2025-11-05
- 2025-09-30: Number of Reporting Units 9 month 1.00 reporting_unit.
| Period end | Number of Reporting Units 9 month |
|---|---|
| 2025-09-30 | 1.00 reporting_unit 10-Q · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |